357 filings
Page 15 of 18
6-K
TRIL
Trillium Therapeutics Inc.
17 Aug 16
Trillium Therapeutics Receives Fda Clearance to Proceed with TTI-621 In Clinical Trial Targeting Solid Tumors and Mycosis Fungoides
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
12 Aug 16
Current report (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
7 Jun 16
Current report (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
31 May 16
Trillium Announces Voting Results from the Annual and Special Meeting of Shareholders
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
18 May 16
Current report (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
13 May 16
Interim Condensed Consolidated Financial Statements
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
21 Apr 16
Current report (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
14 Apr 16
Trillium to Provide Update on CD47 Program at the 2016 American Association for Cancer Research Annual Meeting
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
12 Apr 16
Trillium to Present at the 2016 Annual Needham Health Care Conference
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
23 Mar 16
Current report (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
22 Mar 16
Current report (foreign)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
10 Mar 16
Trillium Announces a $3.4 Million Government Co-funded Translational Research Program
12:00am
40-F
2015 FY
TRIL
Trillium Therapeutics Inc.
9 Mar 16
Annual report (Canada)
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
9 Mar 16
Trillium Reports 2015 Financial and Operating Results
12:00am
6-K
TRIL
Trillium Therapeutics Inc.
8 Mar 16
Current report (foreign)
12:00am
SC 13G
Janus Capital Management LLC
16 Feb 16
Trillium Therapeutics Inc.
12:00am
SC 13G/A
Mottola Thomas D
16 Feb 16
Trillium Therapeutics Inc.
12:00am
SC 13G/A
Point72 Asset Management, L.P.
16 Feb 16
Trillium Therapeutics Inc.
12:00am
SC 13G/A
Flynn James E
16 Feb 16
Trillium Therapeutics Inc.
12:00am
SC 13G/A
Ridgeback Capital Investments L.P.
16 Feb 16
Trillium Therapeutics Inc.
12:00am